Insider Transactions Reported by 20 Insiders of Maze Therapeutics, Inc.

Symbol
MAZE on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Maze Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures IV, L.P. 10%+ Owner $140,662,889 04 Nov 2025
CHARLES J. HOMCY Director $1,280,131 19 Nov 2025
Amy Bachrodt SVP, Finance $519,655 -$606,173 -54% 29 Dec 2025
Atul Dandekar Csbo $423,901 -$2,940,799 -87% 29 Dec 2025
Harold Bernstein President, R&D & CMO $0 -$1,825,355 -100% 29 Dec 2025
RICHARD H. SCHELLER Director $0 22 Sep 2025
Jason V. Coloma Chief Executive Officer, Director 22 Sep 2025
Jonathan E. Lim Director 22 Sep 2025
ARCH Venture Partners X, LLC 10%+ Owner 30 Jan 2025
DANIEL K. SPIEGELMAN Director 22 Sep 2025
Jeffrey K. Tong Director 30 Jan 2025
Misbah Tahir Chief Financial Officer 02 Sep 2025
Catherine A. Sohn Director 22 Sep 2025
Herve Hoppenot Director 06 Oct 2025
Sekar Kathiresan Director 22 Sep 2025
Courtney Phillips GC and Corp. Secretary 22 Sep 2025
Nancy C. Andrews Director 22 Sep 2025
James Brush Director 30 Jan 2025
Alan Colowick Director 30 Jan 2025
Neil Exter Director 22 Sep 2025

Recent Insider Transactions by Companies or Individuals for Maze Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.